Whether PRL-3 is a bona fide oncogene has not yet been addressed in detail, although a report using PRL-3-knockout mice shows that the absence of the PRL-3 gene leads to a 50% decrease of tumor formation in a colon cancer model (Zimmerman et al., 2013). This evidence concerns the gene PTP4A3 and colonic neoplasm.